Glutadon

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/50 (2006.01) A61K 31/655 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2651691

The present invention relates to a pharmaceutical combination product for cancer therapy. The combination product comprises the two active ingredients glutaminase and 6-diazo-5-oxo-L-norleucine (DON). The invention further relates to the use of such a combination product for the treatment of cancers.

La présente invention concerne une préparation pharmaceutique pour le traitement du cancer. La préparation contient deux substances actives, la glutaminase et la 6-diazo-5-oxo-L-norleucine (DON). L'invention concerne également l'utilisation d'une telle préparation pour le traitement de maladies cancéreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glutadon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glutadon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutadon will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1796980

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.